Aniko Barta
Pest, BU 1097, Hungary
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Donor KIR2DS1 reduces the risk of transplant related mortality in HLA-C2 positive young recipients with hematological malignancies treated by myeloablative conditioning.
Journal: PloS one
Published: January 02, 2019
Effective treatment of steroid and therapy-refractory acute graft-versus-host disease with a novel mesenchymal stromal cell product (MSC-FFM).
Journal: Bone marrow transplantation
Published: December 19, 2017
Sex-specific survival difference in association with HLA-DRB1∗04 following allogeneic haematopoietic stem cell transplantation for lymphoid malignancies.
Journal: Human immunology
Published: June 19, 2017
Allogeneic hematopoietic stem cell transplantation in Hungary
Journal: Orvosi hetilap
Published: February 21, 2017
Recipient and donor JAK2 46/1 haplotypes are associated with acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
Journal: Leukemia & lymphoma
Published: July 09, 2016
Early Versus Delayed Autologous Stem Cell Transplantation and Interferon Maintenance in Multiple Myeloma: Single-Center Experience of 18 Years.
Journal: Transplantation proceedings
Published: September 16, 2015
The potential role of HLA-DRB1*11 in the development and outcome of haematopoietic stem cell transplantation-associated thrombotic microangiopathy.
Journal: Bone marrow transplantation
Published: May 27, 2015
Peripheral blood stem cell mobilization and engraftment after autologous stem cell transplantation with biosimilar rhG-CSF.
Journal: Advances in therapy
Published: December 04, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026